Kebba Jobarteh

advertisement

Absorption, Retention and

Empowerment

Addressing the Root Causes of Attrition

Through Scale-up of Community Adherence

Support Groups

Mozambique

• Population: 23.4 million (2011)

• Human Development Index

(165/169)

• Life expectancy 48.4 years

• Mean years of schooling: 1.2

- 33% adult men and 63% adult women illiterate

• Limited human resources and physical infrastructure

₋ > 830,000 births per year, ~65% in health facilities

₋ 50-60% DO NOT have access to health care

₋ Many clinics and hospitals lack continuous access to water (63%), electricity (74%)

₋ Poor roads, seasonal flooding

• >70% rural

National and USG-supported

ART coverage through 2013

400 000

360 000

320 000

280 000

240 000

200 000

160 000

120 000

80 000

40 000

0

2%

4%

0%

10%

2%

20%

8%

37%

18%

48%

27%

44%

53%

51%

45%

49%

45%

30%

32% 32%

34%

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

60%

50%

40%

30%

20%

10%

0%

On Treatment

(USG - FY)

On Treatment

(National - CY)

National

Coverage (USG direct support)

National

Coverage

(MOH)

* Coverage estimates are calculated as those on ART at end of reporting period (MOH - Dec 31, USG - Sep 30), divided by midyear Spectrum estimates from 2012 Demographic Impact Report. 2012-13 USG targets are as proposed in COP12.

Absorptive Capacity

• The public health system in

Mozambique is currently straining to serve the needs of the population

– 3 physicians/100,000 inhabitants

– 21 clinical officers/100,000 inhabitants

– 40 MCH nurses/100,000 inhabitants

– 1.4 million infected

– 603,375 eligible for treatment

– 273,561 alive and on treatment

• Model of HIV care must be adapted

Traditional Retention Strategies

– Pre-ART/ART counseling

– Care package

– Peer educators

– Support groups

– Defaulter tracing

– Community health workers

– SMS messaging

A Different Approach

• Community adherence support groups

(CASG)

– Establish treatment groups with up to 6 members

– One representative from the group visits the health facility every month and does the following:

• Clinical assessment and CD4 count

• Provides feedback to the health facility about the five other members of the group

• Obtains lab results for other members

• Collects one month’s worth of ARV’s for each group member

Results from MSFTête Pilot

Cohort of 1384 ART patients in 12 health facilities in Tête Province

– 291 groups formed

– 12-month retention: 97.5%

– Mortality: 0.2%

– LTFU: 2.3%

– Median follow-up time: 12.9 months

Decroo, T., Telfer, B., Biot, M., Maïkéré, J., Dezembro, S., Cumba, L. I., Dores, C. D., et al.;

Distribution of antiretroviral treatment through selfforming groups of patients in Tête province, Mozambique ; Journal of Acquired Immune Deficiency

Syndromes, February 2011

Patient Level Characteristics

• Median CD4 count at ART initiation: 176 cells/mm 3

• Median amount of time on ART prior to

CAG: 22.3 months

• Median age: 36 years

• 70% female

• Median CD4 count gain: 478.5 cells/mm 3

Before the Monthly Clinic Visit

• All members convene at a place of their choosing to do the following:

– Discuss their health and any other issues that may arise

– Pill counts

– Basic negative screening tool

After the Monthly Clinic Visit

• All members of the group reconvene at a place of their choosing to do the following:

– Report lab results

– Distribute medications

– Convey any health messages received during the clinic visit

Impact at Health Facility

• Reduce number of stable ART patients accessing the health facilities

• Increase capacity of a health facility to enroll new patients

• Increase amount of time staff can dedicate to sick or complex patients

• Decrease congestion at the pharmacy

• Decrease acuity of consultations and admissions due to earlier access to health services

• Improved reporting on patient outcomes

Impact on patient

• Decreased number of health facility visits

• Improved self-monitoring of clinical conditions

• Improved psycho-social support

• Stigma reduction

• Early warning system for illness

• Improved monitoring and resources to address adherence problems

• Social safety net

• Income generation

• Family testing

• Community education

Scale-Up

• Government of Mozambique piloting the model in all 11 Provinces

– 3-6 health facilities per Province

– 3 tiers

• >1000 patients

• 500-10000 patients

• <500 patients

• 12-month pilot with national scale-up pending the results of retrospective evaluation

6 Months of Progress

PROVINCE

Cabo Delgado

Gaza

Inhambane

Manica

Maputo Cidade

Maputo

Provincia

Nampula

Niassa

Sofala

Zambezia

Grand Total

NUMBER OF

GROUPS

51

121

159

94

87

123

84

41

132

189

1081

NUMBER OF

PATIENTS

229

552

727

318

152

561

310

150

492

813

4304

Who is currently eligible

• Non-pregnant

• Stable

• Adult (or at least adult doses of ARVs)

Who could be eligible?

• Pre-ART populations

• Pregnant HIV-infected women

• Children

• Defaulters

• TB infected patients

• HIV/TB co-infected patients

Challenges

• Allowing for a flexible dynamic

• Phased implementation

• Perception of strategy as a panacea

• Staff ownership

• CD4 count monitoring

• Demand creation

• Urban settings

• Links with other adherence and retention strategies

• Patients with the most need may not have access

“The most important aspect of self-management is the realization that people with a chronic condition are those that have the most comprehensive expertise in dealing with that condition.”

-Katarina Kober & Wim Van Damme

Obrigado!

Acknowledgements

HIV-infected and affected Mozambicans

Aleny Couto (MISAU)

Vania Macome (MISAU)

Armando Bucuane (MISAU)

Joe Lara (MISAU)

Tom Decroo (MSF-B)

Sergio Dizembro (MSF-B)

Inacio Malimane (CDC)

Paula Samo Gudo (CDC)

Lisa Nelson (CDC)

Download